Parameters Governing Invasive Disease Propensity of Non-M1 Serotype Group A Streptococci
Author(s) -
Peter G. Maamary,
Martina L. SandersonSmith,
Ramy K. Aziz,
Andrew Hollands,
Jason N. Cole,
Fiona C. McKay,
Jason D. McArthur,
Joshua K. Kirk,
Amanda J. Cork,
Rachael J. Keefe,
Rita G. Kansal,
Hongmin Sun,
William L. Taylor,
Gursharan S. Chhatwal,
David Ginsburg,
Victor Nizet,
Malak Kotb,
Mark J. Walker
Publication year - 2010
Publication title -
journal of innate immunity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.078
H-Index - 64
eISSN - 1662-8128
pISSN - 1662-811X
DOI - 10.1159/000317640
Subject(s) - virulence , biology , serotype , streptococcus , streptococcus pyogenes , streptococcus pneumoniae , microbiology and biotechnology , mutant , disease , virology , immunology , medicine , bacteria , genetics , antibiotics , staphylococcus aureus , gene , pathology
Group A Streptococcus (GAS) causes rare but life-threatening syndromes of necrotizing fasciitis and toxic shock-like syndrome in humans. The GAS serotype M1T1 clone has globally disseminated, and mutations in the control of virulence regulatory sensor kinase (covRS) operon correlate with severe invasive disease. Here, a cohort of non-M1 GAS was screened to determine whether mutation in covRS triggers systemic dissemination in divergent M serotypes. A GAS disease model defining parameters governing invasive propensity of differing M types is proposed. The vast majority of GAS infection is benign. Nonetheless, many divergent M types possess limited capacity to cause invasive infection. M1T1 GAS readily switch to a covRS mutant form that is neutrophil resistant and frequently associated with systemic infection. Whilst non-M1 GAS are shown in this study to less frequently accumulate covRS mutations in vivo, such mutants are isolated from invasive infections and exhibit neutrophil resistance and enhanced virulence. The reduced capacity of non-M1 GAS to switch to the hypervirulent covRS mutant form provides an explanation for the comparatively less frequent isolation of non-M1 serotypes from invasive human infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom